Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of human breast cancers and lung metastatis
Validation of lung metastasis signature (LMS) and its association with risk of developing lung metastasis and with primary tumor size. Experiment Overall Design: 58 tumor samples
ORGANISM(S): Homo sapiens 
2008-06-13 | E-GEOD-5327 | biostudies-arrayexpress
Unknownp16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
Not available
S-EPMC4251957 | biostudies-literature
ProteomicsA mass spectrometry-based proteome map of drug action in lung cancer cell lines
Mass spectrometry-based discovery proteomics is an essential tool for the proximal read-out of cellular drug action. Here, we used a robust proteomic workflow to rapidly and systematically profile the proteomes of five cell lines in response to > 50 drugs. We found that aggregating millions of quant...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-08-06 | MSV000087954 | MassIVE
ProteomicsA mass spectrometry-based proteome map of drug action in lung cancer cell lines
Mass spectrometry-based discovery proteomics is an essential tool for the proximal read-out of cellular drug action. Here, we used a robust proteomic workflow to rapidly and systematically profile the proteomes of five cell lines in response to > 50 drugs. We found that aggregating millions of quant...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-08-06 | MSV000087949 | MassIVE
ProteomicsA mass spectrometry-based proteome map of drug action in lung cancer cell lines Part 6
Mass spectrometry-based discovery proteomics is an essential tool for the proximal read-out of cellular drug action. Here, we used a robust proteomic workflow to rapidly and systematically profile the proteomes of five cell lines in response to > 50 drugs. We found that aggregating millions of quant...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-08-06 | MSV000087955 | MassIVE
ProteomicsA mass spectrometry-based proteome map of drug action in lung cancer cell lines Part 3
Mass spectrometry-based discovery proteomics is an essential tool for the proximal read-out of cellular drug action. Here, we used a robust proteomic workflow to rapidly and systematically profile the proteomes of five cell lines in response to > 50 drugs. We found that aggregating millions of quant...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-08-06 | MSV000087953 | MassIVE
ProteomicsA mass spectrometry-based proteome map of drug action in lung cancer cell lines Part 4
Mass spectrometry-based discovery proteomics is an essential tool for the proximal read-out of cellular drug action. Here, we used a robust proteomic workflow to rapidly and systematically profile the proteomes of five cell lines in response to > 50 drugs. We found that aggregating millions of quant...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2021-08-06 | MSV000087952 | MassIVE
UnknownTranslational development of a tumor junction opening technology.
Not available
S-EPMC9094124 | biostudies-literature
ProteomicsA meta-analysis of phosphoproteomics datasets from Toxoplasma gondii
We performed a meta-analysis over 10 publicly available phosphoproteomics datasets available for Toxoplasma gondii, as part of the PTMeXchange project using standardised analysis pipelines. For the reference genome ME49, in total, 24360 phosphosites were identified at a minimum of 5% FLR in any data...
ORGANISM(S): Toxoplasma gondii 
2026-06-09 | PXD078724 | Pride
Phosphoproteomics Ptmexchange Reanalysis Public data Flr 
UnknownAdaptive Printing of Conductive Microfibers for Seamless Functional Enhancement Across Diverse Surfaces and Shapes
Not available
S-EPMC12287195 | biostudies-literature
Sort   by:  
 Page size